The New York Times

Companies in Africa and India will make generic versions of the pill that could cost as little as $5 per person per year. But access to the drug and other new products in much of Latin America remains uncertain.

The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.

In a recent study, scientists devised a way of reversing the buildup of compounds that lead to some age-related diseases.

The agency is considering whether compounding pharmacies should be allowed to produce BPC-157, TB-500 and other previously banned peptides.

The Agency for Healthcare Research and Quality slowed the awarding of new grants last year. Now it is stopping existing ones.

Senator Bill Cassidy, who is believed to hold the deciding vote in the Senate health committee for Dr. Erica Schwartz’s confirmation, had declined for days to say whether he would back her.

For the first time, officials have acknowledged problems with the No Surprises Act, which has led to huge payments.

Agency scientists are advising against allowing widespread use of several peptide injections. Robert F. Kennedy Jr., the health secretary, has said people should be free to experiment.

The administration canceled federal grants to organizations across the country, accusing them of encouraging premarital sex. New criteria say programs should stress abstinence.

New research also shows that children and high-risk adult populations have been particularly affected.

A new nonprofit wants to streamline gene therapy for diseases often avoided by pharmaceutical companies — making treatment more like a routine procedure than a bespoke drug.

Eighteen Americans were isolated for weeks in a Nebraska quarantine facility after being exposed to the deadly virus on a cruise ship. Many found the experience traumatic.

Genetic prediction models are poised to revolutionize medicine. But because they have been trained on European DNA, they threaten to widen health care disparities.

I was drawn to and worried about this sort of therapy — maybe there were dangers in stirring things up.

The implicated products were marketed under several brands, and had been shipped as recently as Thursday.